Phosphorylation and microtubule association of the Opitz syndrome protein mid-1 is regulated by protein phosphatase 2A via binding to the regulatory subunit α4
- 22 May 2001
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 98 (12) , 6650-6655
- https://doi.org/10.1073/pnas.111154698
Abstract
Opitz syndrome (OS) is a human genetic disease characterized by deformities such as cleft palate that are attributable to defects in embryonic development at the midline. Gene mapping has identified OS mutations within a protein called Mid1. Wild-type Mid1 predominantly colocalizes with microtubules, in contrast to mutant versions of Mid1 that appear clustered in the cytosol. Using yeast two-hybrid screening, we found that the alpha4-subunit of protein phosphatases 2A/4/6 binds Mid1. Epitope-tagged alpha4 coimmunoprecipitated endogenous or coexpressed Mid1 from COS7 cells, and this required only the conserved C-terminal region of alpha4. Localization of Mid1 and alpha4 was influenced by one another in transiently transfected cells. Mid1 could recruit alpha4 onto microtubules, and high levels of alpha4 could displace Mid1 into the cytosol. Metabolic (32)P labeling of cells showed that Mid1 is a phosphoprotein, and coexpression of full-length alpha4 decreased Mid1 phosphorylation, indicative of a functional interaction. Association of green fluorescent protein-Mid1 with microtubules in living cells was perturbed by inhibitors of MAP kinase activation. The conclusion is that Mid1 association with microtubules, which seems important for normal midline development, is regulated by dynamic phosphorylation involving MAP kinase and protein phosphatase that is targeted specifically to Mid1 by alpha4. Human birth defects may result from environmental or genetic disruption of this regulatory cycle.Keywords
This publication has 24 references indexed in Scilit:
- New mutations in MID1 provide support for loss of function as the cause of X-linked Opitz syndromeHuman Molecular Genetics, 2000
- Glycogen Synthase Association with the Striated Muscle Glycogen-targeting Subunit of Protein Phosphatase-1Journal of Biological Chemistry, 2000
- Mutation of Tyr307 and Leu309 in the Protein Phosphatase 2A Catalytic Subunit Favors Association with the α4 Subunit Which Promotes Dephosphorylation of Elongation Factor-2Biochemistry, 1999
- The TOR nutrient signalling pathway phosphorylates NPR1 and inhibits turnover of the tryptophan permeaseThe EMBO Journal, 1998
- Inhibition of the M r 70,000 S6 kinase pathway by rapamycin results in chromosome malsegregation in yeast and mammalian cellsChromosoma, 1998
- Opitz G/BBB syndrome, a defect of midline development, is due to mutations in a new RING finger gene on Xp22Nature Genetics, 1997
- B cell receptor-associated protein α4 displays rapamycin-sensitive binding directly to the catalytic subunit of protein phosphatase 2AProceedings of the National Academy of Sciences, 1997
- Yeast GAL4 Two-Hybrid System: A Genetic System to Identify Proteins That interact with a Target ProteinPublished by Springer Nature ,1996
- Nutrients, via the Tor proteins, stimulate the association of Tap42 with type 2A phosphatases.Genes & Development, 1996
- Protein Phosphatase Type-1 and Glycogen Bind to a Domain in the Skeletal Muscle Regulatory Subunit Containing Conserved Hydrophobic Sequence MotifsBiochemistry, 1996